litlas
Log inCreate account

Michael Andreeff

Active 1979–2025

Also published as
MICHAEL ANDREEFF
365
Papers
59,532
Citations
138
h-index
350
i10-index

Citations

Citations per year for Michael Andreeff1968: 2 citations1975: 2 citations1980: 5 citations1981: 2 citations1982: 5 citations1983: 5 citations1984: 11 citations1985: 31 citations1986: 19 citations1987: 23 citations1988: 22 citations1989: 18 citations1990: 19 citations1991: 39 citations1992: 52 citations1993: 54 citations1994: 42 citations1995: 53 citations1996: 56 citations1997: 75 citations1998: 84 citations1999: 135 citations2000: 164 citations2001: 179 citations2002: 211 citations2003: 283 citations2004: 247 citations2005: 259 citations2006: 335 citations2007: 412 citations2008: 543 citations2009: 585 citations2010: 646 citations2011: 599 citations2012: 615 citations2013: 599 citations2014: 547 citations2015: 563 citations2016: 478 citations2017: 585 citations2018: 545 citations2019: 1,788 citations2020: 1,898 citations2021: 1,997 citations2022: 1,633 citations2023: 1,324 citations2024: 2,009 citations2025: 1,023 citations2026: 11 citations1969–1974: no citations, so these years are not shown1976–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,007 citing papers, 31.9% of this breakdownChina: 2,642 citing papers, 12% of this breakdownGermany: 1,293 citing papers, 5.9% of this breakdownItaly: 1,179 citing papers, 5.4% of this breakdownUnited Kingdom: 1,103 citing papers, 5% of this breakdownFrance: 811 citing papers, 3.7% of this breakdownCanada: 654 citing papers, 3% of this breakdownJapan: 587 citing papers, 2.7% of this breakdownSpain: 523 citing papers, 2.4% of this breakdownAustralia: 516 citing papers, 2.3% of this breakdownNetherlands: 452 citing papers, 2.1% of this breakdownIndia: 377 citing papers, 1.7% of this breakdown
0%31.9%Other 21.9%

Institutions

Fields

  • Medicine53.7%
  • Biochemistry, Genetics and Molecular Biology38.4%
  • Immunology and Microbiology3.6%
  • Neuroscience1.1%
  • Engineering1%
  • Chemistry0.4%
  • Other1.8%

Topics

  • Acute Myeloid Leukemia Research7.2%
  • Cancer Cells and Metastasis2.6%
  • Mesenchymal stem cell research2.4%
  • Cell death mechanisms and regulation2.3%
  • MicroRNA in disease regulation2.3%
  • Chronic Myeloid Leukemia Treatments2.2%
  • Other81%

Coauthors

All papers

Open in search
  1. Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality

    Authors: Jo Ishizawa, Sarah F. Zarabi, R. Eric Davis, Ondrej Halgas, Takenobu Nii, Yulia Jitkova, Ran Zhao, Jonathan St‐Germain, Lauren Heese, Grace Egan, Vivian Ruvolo, Samir H. Barghout, Yuki Nishida, Rose Hurren, Wencai Ma, Marcela Gronda, Todd Link, Keith S. Wong, Mark Mabanglo, Kensuke Kojima, Gautam Borthakur, Neil MacLean, Man Chun John, Andrew B. Leber, Mark D. Minden, Walid A. Houry, Hagop M. Kantarjian, Martin Stogniew, Brian Raught, E.F. Pai, Aaron D. Schimmer, Michael Andreeff - Cancer Cell 2019 cited by 354

  2. MDM2 inhibition: an important step forward in cancer therapy

    Authors: Marina Konopleva, Giovanni Martinelli, Naval Daver, Cristina Papayannidis, Andrew H. Wei, Brian Higgins, Marion Ott, John Mascarenhas, Michael Andreeff - Leukemia 2020 cited by 384

  3. Bone marrow niches in haematological malignancies

    Authors: Simón Méndez‐Ferrer, Dominique Bonnet, David P. Steensma, Robert P. Hasserjian, Irene M. Ghobrial, John G. Gribben, Michael Andreeff, Daniela S. Krause - Nature reviews. Cancer 2020 cited by 468

  4. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

    Authors: Naval Daver, Guillermo Garcia‐Manero, Sreyashi Basu, Prajwal Boddu, Mansour Alfayez, Jörge E. Cortes, Marina Konopleva, Farhad Ravandi‐Kashani, Elias Jabbour, Tapan M. Kadia, Graciela M. Nogueras‐González, Jing Ning, Naveen Pemmaraju, Courtney D. DiNardo, Michael Andreeff, Sherry Pierce, Tauna Gordon, Steven M. Kornblau, Wilmer Flores, Zainab Alhamal, Carlos E. Bueso‐Ramos, Jeffrey L. Jorgensen, Keyur P. Patel, Jorge Blando, James P. Allison, Padmanee Sharma, Hagop M. Kantarjian - Cancer Discovery 2018 cited by 571

  5. Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

    Authors: Rongqing Pan, Leah J. Hogdal, Juliana M. Benito, Donna Bucci, Lina Han, Gautam Borthakur, Jörge E. Cortes, Daniel J. DeAngelo, LaKeisha Debose, Hong Mu, Hartmut Döhner, Verena I. Gaidzik, Ilene Galinsky, Leonard S. Golfman, Torsten Haferlach, Karine G. Harutyunyan, Jianhua Hu, Joel D. Leverson, Guido Marcucci, Markus Müschen, Rachel Newman, Eugene Park, Peter P. Ruvolo, Vivian Ruvolo, Jeremy Ryan, Sonja Schindela, Patrick A. Zweidler‐McKay, Richard M. Stone, Hagop M. Kantarjian, Michael Andreeff, Marina Konopleva, Anthony Letai - Cancer Discovery 2013 cited by 735

  6. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

    Authors: Kiyomi Morita, Feng Wang, Katharina Jahn, Tianyuan Hu, Tomoyuki Tanaka, Yuya Sasaki, Jack Kuipers, Sanam Loghavi, Sa A. Wang, Yuanqing Yan, Ken Furudate, Jairo Matthews, Latasha Little, Curtis Gumbs, Jianhua Zhang, Xingzhi Song, Erika J. Thompson, Keyur P. Patel, Carlos E. Bueso‐Ramos, Courtney D. DiNardo, Farhad Ravandi, Elias Jabbour, Michael Andreeff, Jörge E. Cortes, Kapil N. Bhalla, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Marina Konopleva, Daisuke Nakada, Nicholas E. Navin, Niko Beerenwinkel, P. Andrew Futreal, Koichi Takahashi - Nature Communications 2020 cited by 387

  7. Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

    Authors: Qi Zhang, Bridget Riley‐Gillis, Lina Han, Yannan Jia, Alessia Lodi, Haijiao Zhang, Saravanan Ganesan, Rongqing Pan, Sergej Konoplev, Shannon Sweeney, Jeremy Ryan, Yulia Jitkova, Kenneth Dunner, Shaun Grosskurth, Priyanka Vijay, Sujana Ghosh, Charles Lu, Wencai Ma, Stephen E. Kurtz, Vivian Ruvolo, Helen Ma, Connie C. Weng, Cassandra L. Ramage, Natalia Baran, Ce Shi, Tianyu Cai, R. Eric Davis, Venkata Lokesh Battula, Yingchang Mi, Jing Wang, Courtney D. DiNardo, Michael Andreeff, Jeffery W. Tyner, Aaron D. Schimmer, Anthony Letai, Rose Ann Padua, Carlos E. Bueso‐Ramos, Stefano Tiziani, Joel D. Leverson, Relja Popovic, Marina Konopleva - Signal Transduction and Targeted Therapy 2022 cited by 181

  8. Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia

    Authors: Courtney D. DiNardo, Curtis A. Lachowiez, Koichi Takahashi, Sanam Loghavi, Lianchun Xiao, Tapan M. Kadia, Naval Daver, Maria Adeoti, Nicholas J. Short, Koji Sasaki, Sa Wang, Gautam Borthakur, Ghayas C. Issa, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Guillermo Montalban‐Bravo, Lucia Masárová, Musa Yılmaz, Nitin Jain, Michael Andreeff, Elias Jabbour, Guillermo Garcia‐Manero, Steven M. Kornblau, Farhad Ravandi, Marina Konopleva, Hagop M. Kantarjian - Journal of Clinical Oncology 2021 cited by 334

  9. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

    Authors: Courtney D. DiNardo, Abhishek Maiti, Caitlin R. Rausch, Naveen Pemmaraju, Kiran Naqvi, Naval Daver, Tapan M. Kadia, Gautam Borthakur, Maro Ohanian, Yesid Alvarado, Ghayas C. Issa, Guillermo Montalban‐Bravo, Nicholas J. Short, Musa Yılmaz, Prithviraj Bose, Elias Jabbour, Koichi Takahashi, Jan A. Burger, Guillermo Garcia‐Manero, Nitin Jain, Steven M. Kornblau, Philip A. Thompson, Zeev Estrov, Lucia Masárová, Koji Sasaki, Srđan Verstovšek, Alessandra Ferrajoli, William Weirda, Sa A. Wang, Sergej Konoplev, Zhining Chen, Sherry Pierce, Jing Ning, Wei Qiao, Farhad Ravandi, Michael Andreeff, John S. Welch, Hagop M. Kantarjian, Marina Konopleva - The Lancet Haematology 2020 cited by 331

  10. Therapeutic implications of menin inhibition in acute leukemias

    Authors: Ghayas C. Issa, Farhad Ravandi, Courtney D. DiNardo, Elias Jabbour, Hagop M. Kantarjian, Michael Andreeff - Leukemia 2021 cited by 189

  11. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

    Authors: Ismael Samudio, Romain Harmancey, Michael Fiegl, Hagop M. Kantarjian, Marina Konopleva, Borys Korchin, Kumar Kaluarachchi, William G. Bornmann, Seshagiri Duvvuri, Heinrich Taegtmeyer, Michael Andreeff - Journal of Clinical Investigation 2009 cited by 699

  12. The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia

    Authors: Patrick Williams, Sreyashi Basu, Guillermo Garcia‐Manero, Christopher S. Hourigan, Karolyn A. Oetjen, Jörge E. Cortes, Farhad Ravandi, Elias Jabbour, Zainab Alhamal, Marina Konopleva, Jing Ning, Lianchun Xiao, Juliana Hidalgo Lopez, Steve Kornblau, Michael Andreeff, Wilmer Flores, Carlos E. Bueso‐Ramos, Jorge Blando, Pallavi Galera, Katherine R. Calvo, Gheath Alatrash, James P. Allison, Hagop M. Kantarjian, Padmanee Sharma, Naval Daver - Cancer 2018 cited by 341

  13. Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production

    Authors: Jong Bok Lee, Dilshad H. Khan, Rose Hurren, Mingjing Xu, Yoosu Na, Hyeonjeong Kang, Sara Mirali, Xiaoming Wang, Marcela Gronda, Yulia Jitkova, Neil MacLean, Andrea Arruda, Zoe Alaniz, Marina Konopleva, Michael Andreeff, Mark D. Minden, Zhang Li, Aaron D. Schimmer - Blood 2021 cited by 145

  14. Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

    Authors: Michael Andreeff, Kevin R. Kelly, Karen Yee, Sarit Assouline, Roger Strair, Leslie Popplewell, David Bowen, Giovanni Martinelli, Mark W. Drummond, Paresh Vyas, Mark Kirschbaum, Swaminathan P. Iyer, Vivian Ruvolo, Graciela M. Nogueras‐González, Xuelin Huang, Gong Chen, Bradford Graves, Steven Blotner, Peter J. Bridge, Lori Jukofsky, Steve Middleton, Monica Reckner, Ruediger Rueger, Jianguo Zhi, Gwen Nichols, Kensuke Kojima - Clinical Cancer Research 2015 cited by 353

  15. Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial

    Authors: Naval Daver, Monique Dail, Jacqueline S. Garcia, Brian A. Jonas, Karen Yee, Kevin R. Kelly, Norbert Vey, Sarit Assouline, Gail J. Roboz, Stefania Paolini, Daniel A. Pollyea, Agostino Tafuri, Joseph Brandwein, Arnaud Pigneux, Bayard L. Powell, Pierre Fenaux, Rebecca L. Olin, Giuseppe Visani, Giovanni Martinelli, Maika Onishi, Jue Wang, Weize Huang, Cherie Green, Marion Ott, Wan‐Jen Hong, Marina Konopleva, Michael Andreeff - Blood 2022 cited by 102

  16. Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy

    Authors: Rongqing Pan, Vivian Ruvolo, Hong Mu, Joel D. Leverson, Gwen Nichols, John C. Reed, Marina Konopleva, Michael Andreeff - Cancer Cell 2017 cited by 309

  17. Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging

    Authors: Shannon Kidd, Erika L. Spaeth, Jennifer L. Dembinski, Martin Dietrich, Keri Watson, Ann H. Klopp, Venkata Lokesh Battula, Micheal Weil, Michael Andreeff, Frank C. Marini - Stem Cells 2009 cited by 680

  18. Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens

    Authors: Abhishek Maiti, Caitlin R. Rausch, Jörge E. Cortes, Naveen Pemmaraju, Naval Daver, Farhad Ravandi, Guillermo Garcia‐Manero, Gautam Borthakur, Kiran Naqvi, Maro Ohanian, Nicholas J. Short, Yesid Alvarado, Tapan M. Kadia, Koichi Takahashi, Musa Yılmaz, Nitin Jain, Steven M. Kornblau, Guillermo Montalban‐Bravo, Koji Sasaki, Michael Andreeff, Prithiviraj Bose, Alessandra Ferrajoli, Ghayas C. Issa, Elias Jabbour, Lucia Masárová, Philip A. Thompson, Sa Wang, Sergej Konoplev, Sherry Pierce, Jing Ning, Wei Qiao, John S. Welch, Hagop M. Kantarjian, Courtney D. DiNardo, Marina Konopleva - Haematologica 2020 cited by 173

  19. Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

    Authors: Tapan M. Kadia, Patrick K. Reville, Xuemei Wang, Caitlin R. Rausch, Gautam Borthakur, Naveen Pemmaraju, Naval Daver, Courtney D. DiNardo, Koji Sasaki, Ghayas C. Issa, Maro Ohanian, Guillermo Montalban‐Bravo, Nicholas J. Short, Nitin Jain, Alessandra Ferrajoli, Kapil N. Bhalla, Elias Jabbour, Koichi Takahashi, Rashmi Malla, Kelly Quagliato, Rashmi Kanagal‐Shamanna, Uday Popat, Michael Andreeff, Guillermo Garcia‐Manero, Marina Konopleva, Farhad Ravandi, Hagop M. Kantarjian - Journal of Clinical Oncology 2022 cited by 114

  20. Cancer stem cell definitions and terminology: the devil is in the details

    Authors: Peter Valent, Dominique Bonnet, Ruggero De Maria, Tsvee Lapidot, Mhairi Copland, Junia V. Melo, Christine Chomienne, Fumihiko Ishikawa, Jan Jacob Schuringa, Giorgio Stassi, Brian J.P. Huntly, Harald Herrmann, Jean Soulier, Alexander Roesch, Gerrit Jan Schuurhuis, Stefan Wöhrer, Michel Arock, Johannes Zuber, Sabine Cerny‐Reiterer, Hans Erik Johnsen, Michael Andreeff, Connie J. Eaves - Nature reviews. Cancer 2012 cited by 690

  21. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis

    Authors: Venkata Lokesh Battula, Yuexi Shi, Kurt W. Evans, Rui Yu Wang, Erika L. Spaeth, Rodrigo Jácamo, Rudy Guerra, Ayşegül A. Şahin, Frank C. Marini, Gabriel N. Hortobágyi, Sendurai A. Mani, Michael Andreeff - Journal of Clinical Investigation 2012 cited by 293

  22. Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia

    Authors: Nicholas J. Short, Guillermo Montalban‐Bravo, Hyunsoo Hwang, Jing Ning, Miguel Franquiz, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Courtney D. DiNardo, Farhad Ravandi, Guillermo Garcia‐Manero, Koichi Takahashi, Marina Konopleva, Naval Daver, Ghayas C. Issa, Michael Andreeff, Hagop M. Kantarjian, Tapan M. Kadia - Blood Advances 2020 cited by 181

  23. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

    Authors: Marina Konopleva, Rooha Contractor, Twee Tsao, Ismael Samudio, Peter P. Ruvolo, Shinichi Kitada, Xingming Deng, Dayong Zhai, Yue-Xi Shi, Thomas B. Sneed, Monique Verhaegen, Marı́a S. Soengas, Vivian Ruvolo, Teresa McQueen, Wendy Schober, Julie C. Watt, Tilahun Jiffar, Xiaoyang Ling, Frank C. Marini, David Harris, Martin Dietrich, Zeev Estrov, James A. McCubrey, W. Stratford May, John C. Reed, Michael Andreeff - Cancer Cell 2006 cited by 1,011

  24. Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)

    Authors: Ghayas C. Issa, Branko Cuglievan, Courtney D. DiNardo, Nicholas J. Short, David McCall, Amber Gibson, César Núnêz, Miriam B. Garcia, Michael Roth, Aram Bidikian, Allison Pike, Sheila Tan, Brianna Kammerer, Musa Yılmaz, Tapan M. Kadia, Naveen Pemmaraju, Maro Ohanian, Naval Daver, Elias Jabbour, Gautam Borthakur, Farhad Ravandi, Guillermo Garcia‐Manero, Michael Andreeff, Hagop M. Kantarjian - Blood 2023 cited by 46